• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 ACCUCATH ACE INTRAVASCULAR CATHETER 22GX1.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 ACCUCATH ACE INTRAVASCULAR CATHETER 22GX1.25; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number N/A
Medical Device Problem Codes Material Frayed (1262); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 11/18/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported by the customer that "accucath - retained guidewire in patient.Surgery was needed for removal." 12/5/22 additional information provided: vascular access team attempted to place an extended dwell intravenous line on the left upper extremity (accucath ace intravascular catheter 22g 1.25 inch) on (b)(6) 2022.The guidewire malfunctioned and was partially retained.The intravenous catheter and guidewire were not able to be removed from the patient's extremity.The break was noticed during insertion and confirmed with x-ray of left arm and ultrasound.Surgical team notified after removal.Surgery required to remove broken piece on (b)(6) 2022, operative note indicates a successful removal of the retained foreign body.Surgery was uncomplicated and no long-term patient effects.Patient is being treated for rsv.
 
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of regt4148 showed one other similar product complaint(s) from this lot number.Device not returned.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a fractured guidewire was confirmed.The product returned for evaluation was two 22ga x 1.25¿ accucath ace peripheral iv catheter assemblies.Usage residues were visible on both samples.Both samples were received with the safeties engaged.The needles were fully withdrawn into the housings.The catheters had been advanced and were not returned for evaluation.Inspection of the first sample (sample 1) revealed a break in the guidewire approximately 1cm distal of the needle tip.Microscopic inspection of the break in the guidewire revealed a granular fracture surface.A region of increased luster was observed on one edge of the fracture surface.Scoring marks were observed leading into the region of increased luster.Following disengagement of the safety mechanism, manipulation of the guidewire slider revealed the wire to be mobile within the needle shaft.Microscopic inspection of the needle revealed deformation along the proximal edge of the bevel.The bevel edge buckled and flared outward and in the proximal direction.The break features and needle deformation were consistent with damage caused by the guidewire being pulled against the proximal edge of the needle bevel.Such damage may occur if the guidewire tip becomes constrained, causing the wire to fold over the needle as the needle is inserted.Gross, microscopic and functional evaluation of the second sample (sample 2) was unremarkable.The guidewire was undamaged.The sample appeared to have functioned as intended and may have been returned as a reference sample.H3 other text : evaluation findings are in section h.11.
 
Event or Problem Description
It was reported by the customer that "accucath - retained guidewire in patient.Surgery was needed for removal." 12/5/22 additional information provided: vascular access team attempted to place an extended dwell intravenous line on the left upper extremity (accucath ace intravascular catheter 22g 1.25 inch) on (b)(6) 2022.The guidewire malfunctioned and was partially retained.The intravenous catheter and guidewire were not able to be removed from the patient's extremity.The break was noticed during insertion and confirmed with x-ray of left arm and ultrasound.Surgical team notified after removal.Surgery required to remove broken piece on (b)(6) 2022, operative note indicates a successful removal of the retained foreign body.Surgery was uncomplicated and no long-term patient effects.Patient is being treated for rsv.(b)(6) 2022: clarification call with customer attempted placement was left upper extremity, mid forearm.Resistance was noted during retraction after the retraction button was pressed, no complications noted during insertion.Subsequent imagining noted that the catheter and guidewire were found within left forearm and were left in place.As noted during imaging, 'the radiopaque guidewire extended rom mind-forearm.Guidewire was likely in vessel, but catheter tip was not.Retrieved following day.' wire fragment has been removed from the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUCATH ACE INTRAVASCULAR CATHETER 22GX1.25
Common Device Name
CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15988365
Report Number3006260740-2022-05749
Device Sequence Number14682605
Product Code FOZ
UDI-Device Identifier00801741137938
UDI-Public(01)00801741137938
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
PMA/510(K) Number
K162894
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Other,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2023
Device Model NumberN/A
Device Catalogue NumberAC1221250
Device Lot NumberREGT4148
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/29/2022
Supplement Date Received by Manufacturer01/12/2023
Initial Report FDA Received Date12/15/2022
Supplement Report FDA Received Date01/19/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/01/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age6 MO
Patient SexFemale
Patient Weight7 KG
-
-